Characterization of Multidrug Resistance P-Glycoprotein Transport Function with an Organotechnetium Cation

David Piwnica-Worms, Vallabhaneni V. Rao, James F. Kronauge, James M. Croop

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Multidrug resistance (MDR) in mammalian cells and tumors is associated with overexpression of an ~170 kDa integral membrane efflux transporter, the MDR1 P-glycoprotein. Hexakis(2- methoxyisobutyl isonitrile)technetium(I) (Tc-SESTAMIBI), a γ-emitting lipophilic cationic metallopharmaceutical, has recently been shown to be a P-glycoprotein transport substrate. Exploiting the negligible lipid membrane adsorption properties of this organometallic substrate, we studied the transport kinetics, pharmacology, drug binding, and modulation of P-glycoprotein in cell preparations derived from a variety of species and selection strategies, including SW-1573, V79, Alex, and CHO drug-sensitive cells and in IT A, LZ-8, and Alex/A.5 MDR cells. Rapid cell accumulation (t1/2 ≈ 6 min) of the agent to a steady state was observed which was inversely proportional to immunodetectable levels of P-glycoprotein. Many MDR cytotoxic agents inhibited P-glycoprotein-mediated Tc-SESTAMIBI efflux, thereby enhancing organometallic cation accumulation. Median effective concentrations (EC50; wM) were as follows: vinblastine, 13; daunomycin, 55; idarubicin, 65; actinomycin D, 235; colchicine, minimal inhibition; adriamycin, no effect. P-glycoprotein modulators generally demonstrated significantly greater potency (EC50; M): SDZ PSC 833, 0.08; cyclosporin A, 1.3; verapamil, 4.1; quinidine, 6.4; prazosin, >300. Modulator-induced enhancement up to 100-fold was observed with Hill coefficients %1, consistent with simple Michaelis-Menten kinetics. Vanadate was an efficacious transport inhibitor, while agents usually not included in the MDR phenotype were without effect. Scatchard analysis showed quinidine to be a noncompetitive inhibitor of P-glycoprotein-mediated Tc-SESTAMIBI transport, indicating allosteric effector sites on P-glycoprotein. The lipid bilayer adsorbing agents tetraphenyl borate and phloretin induced large increases in final Tc-SESTAMIBI accumulation, showing maximal accumulations 2-fold greater than classic MDR modulators and Hill coefficients » 2. In V79 and 77A cells, modulators of PKC activity altered Tc-SESTAMIBI accumulation, while there was no indication of modulation of P-glycoproteinmediated Tc-SESTAMIBI transport by hypotonic buffer, extracellular ATP, Cl-, or K+ (membrane potential). While recognized and avidly transported by the P-glycoprotein at buffer concentrations as low as 7 pM, Tc-SESTAMIBI at up to 100 uM only minimally modulated the cytotoxic action of colchicine, doxorubicin, or vinblastine in MDR cells. In conclusion, transport analysis with Tc-SESTAMIBI is a sensitive assay for detecting functional expression of low levels of P-glycoprotein and for the quantitative characterization of transporter modulation and regulation. The biochemical data favor a high Km, high capacity allosterically modulated translocation mechanism for P-glycoprotein-mediated transport of this organometallic cation. In addition, the known physicochemical properties of Tc-SESTAMIBI combined with effects of the membrane adsorbing agents indicate that lipid-protein interactions are critical for transport of this metallopharmaceutical and would suggest that this drug gains access to protein transport domains from the lipid phase with rapid time constants.

Original languageEnglish (US)
Pages (from-to)12210-12220
Number of pages11
JournalBiochemistry
Volume34
Issue number38
DOIs
StatePublished - Sep 1995

Fingerprint

Multiple Drug Resistance
P-Glycoprotein
Cations
Modulators
Organometallics
Quinidine
Vinblastine
Colchicine
Modulation
Membranes
Doxorubicin
Buffers
Phloretin
Pharmaceutical Preparations
Idarubicin
Allosteric Site
Lipids
Borates
Lipid bilayers
Kinetics

ASJC Scopus subject areas

  • Biochemistry

Cite this

Characterization of Multidrug Resistance P-Glycoprotein Transport Function with an Organotechnetium Cation. / Piwnica-Worms, David; Rao, Vallabhaneni V.; Kronauge, James F.; Croop, James M.

In: Biochemistry, Vol. 34, No. 38, 09.1995, p. 12210-12220.

Research output: Contribution to journalArticle

Piwnica-Worms, David ; Rao, Vallabhaneni V. ; Kronauge, James F. ; Croop, James M. / Characterization of Multidrug Resistance P-Glycoprotein Transport Function with an Organotechnetium Cation. In: Biochemistry. 1995 ; Vol. 34, No. 38. pp. 12210-12220.
@article{a86e67831847457fac0c9bbc90305f56,
title = "Characterization of Multidrug Resistance P-Glycoprotein Transport Function with an Organotechnetium Cation",
abstract = "Multidrug resistance (MDR) in mammalian cells and tumors is associated with overexpression of an ~170 kDa integral membrane efflux transporter, the MDR1 P-glycoprotein. Hexakis(2- methoxyisobutyl isonitrile)technetium(I) (Tc-SESTAMIBI), a γ-emitting lipophilic cationic metallopharmaceutical, has recently been shown to be a P-glycoprotein transport substrate. Exploiting the negligible lipid membrane adsorption properties of this organometallic substrate, we studied the transport kinetics, pharmacology, drug binding, and modulation of P-glycoprotein in cell preparations derived from a variety of species and selection strategies, including SW-1573, V79, Alex, and CHO drug-sensitive cells and in IT A, LZ-8, and Alex/A.5 MDR cells. Rapid cell accumulation (t1/2 ≈ 6 min) of the agent to a steady state was observed which was inversely proportional to immunodetectable levels of P-glycoprotein. Many MDR cytotoxic agents inhibited P-glycoprotein-mediated Tc-SESTAMIBI efflux, thereby enhancing organometallic cation accumulation. Median effective concentrations (EC50; wM) were as follows: vinblastine, 13; daunomycin, 55; idarubicin, 65; actinomycin D, 235; colchicine, minimal inhibition; adriamycin, no effect. P-glycoprotein modulators generally demonstrated significantly greater potency (EC50; M): SDZ PSC 833, 0.08; cyclosporin A, 1.3; verapamil, 4.1; quinidine, 6.4; prazosin, >300. Modulator-induced enhancement up to 100-fold was observed with Hill coefficients {\%}1, consistent with simple Michaelis-Menten kinetics. Vanadate was an efficacious transport inhibitor, while agents usually not included in the MDR phenotype were without effect. Scatchard analysis showed quinidine to be a noncompetitive inhibitor of P-glycoprotein-mediated Tc-SESTAMIBI transport, indicating allosteric effector sites on P-glycoprotein. The lipid bilayer adsorbing agents tetraphenyl borate and phloretin induced large increases in final Tc-SESTAMIBI accumulation, showing maximal accumulations 2-fold greater than classic MDR modulators and Hill coefficients » 2. In V79 and 77A cells, modulators of PKC activity altered Tc-SESTAMIBI accumulation, while there was no indication of modulation of P-glycoproteinmediated Tc-SESTAMIBI transport by hypotonic buffer, extracellular ATP, Cl-, or K+ (membrane potential). While recognized and avidly transported by the P-glycoprotein at buffer concentrations as low as 7 pM, Tc-SESTAMIBI at up to 100 uM only minimally modulated the cytotoxic action of colchicine, doxorubicin, or vinblastine in MDR cells. In conclusion, transport analysis with Tc-SESTAMIBI is a sensitive assay for detecting functional expression of low levels of P-glycoprotein and for the quantitative characterization of transporter modulation and regulation. The biochemical data favor a high Km, high capacity allosterically modulated translocation mechanism for P-glycoprotein-mediated transport of this organometallic cation. In addition, the known physicochemical properties of Tc-SESTAMIBI combined with effects of the membrane adsorbing agents indicate that lipid-protein interactions are critical for transport of this metallopharmaceutical and would suggest that this drug gains access to protein transport domains from the lipid phase with rapid time constants.",
author = "David Piwnica-Worms and Rao, {Vallabhaneni V.} and Kronauge, {James F.} and Croop, {James M.}",
year = "1995",
month = "9",
doi = "10.1021/bi00038a015",
language = "English (US)",
volume = "34",
pages = "12210--12220",
journal = "Biochemistry",
issn = "0006-2960",
publisher = "American Chemical Society",
number = "38",

}

TY - JOUR

T1 - Characterization of Multidrug Resistance P-Glycoprotein Transport Function with an Organotechnetium Cation

AU - Piwnica-Worms, David

AU - Rao, Vallabhaneni V.

AU - Kronauge, James F.

AU - Croop, James M.

PY - 1995/9

Y1 - 1995/9

N2 - Multidrug resistance (MDR) in mammalian cells and tumors is associated with overexpression of an ~170 kDa integral membrane efflux transporter, the MDR1 P-glycoprotein. Hexakis(2- methoxyisobutyl isonitrile)technetium(I) (Tc-SESTAMIBI), a γ-emitting lipophilic cationic metallopharmaceutical, has recently been shown to be a P-glycoprotein transport substrate. Exploiting the negligible lipid membrane adsorption properties of this organometallic substrate, we studied the transport kinetics, pharmacology, drug binding, and modulation of P-glycoprotein in cell preparations derived from a variety of species and selection strategies, including SW-1573, V79, Alex, and CHO drug-sensitive cells and in IT A, LZ-8, and Alex/A.5 MDR cells. Rapid cell accumulation (t1/2 ≈ 6 min) of the agent to a steady state was observed which was inversely proportional to immunodetectable levels of P-glycoprotein. Many MDR cytotoxic agents inhibited P-glycoprotein-mediated Tc-SESTAMIBI efflux, thereby enhancing organometallic cation accumulation. Median effective concentrations (EC50; wM) were as follows: vinblastine, 13; daunomycin, 55; idarubicin, 65; actinomycin D, 235; colchicine, minimal inhibition; adriamycin, no effect. P-glycoprotein modulators generally demonstrated significantly greater potency (EC50; M): SDZ PSC 833, 0.08; cyclosporin A, 1.3; verapamil, 4.1; quinidine, 6.4; prazosin, >300. Modulator-induced enhancement up to 100-fold was observed with Hill coefficients %1, consistent with simple Michaelis-Menten kinetics. Vanadate was an efficacious transport inhibitor, while agents usually not included in the MDR phenotype were without effect. Scatchard analysis showed quinidine to be a noncompetitive inhibitor of P-glycoprotein-mediated Tc-SESTAMIBI transport, indicating allosteric effector sites on P-glycoprotein. The lipid bilayer adsorbing agents tetraphenyl borate and phloretin induced large increases in final Tc-SESTAMIBI accumulation, showing maximal accumulations 2-fold greater than classic MDR modulators and Hill coefficients » 2. In V79 and 77A cells, modulators of PKC activity altered Tc-SESTAMIBI accumulation, while there was no indication of modulation of P-glycoproteinmediated Tc-SESTAMIBI transport by hypotonic buffer, extracellular ATP, Cl-, or K+ (membrane potential). While recognized and avidly transported by the P-glycoprotein at buffer concentrations as low as 7 pM, Tc-SESTAMIBI at up to 100 uM only minimally modulated the cytotoxic action of colchicine, doxorubicin, or vinblastine in MDR cells. In conclusion, transport analysis with Tc-SESTAMIBI is a sensitive assay for detecting functional expression of low levels of P-glycoprotein and for the quantitative characterization of transporter modulation and regulation. The biochemical data favor a high Km, high capacity allosterically modulated translocation mechanism for P-glycoprotein-mediated transport of this organometallic cation. In addition, the known physicochemical properties of Tc-SESTAMIBI combined with effects of the membrane adsorbing agents indicate that lipid-protein interactions are critical for transport of this metallopharmaceutical and would suggest that this drug gains access to protein transport domains from the lipid phase with rapid time constants.

AB - Multidrug resistance (MDR) in mammalian cells and tumors is associated with overexpression of an ~170 kDa integral membrane efflux transporter, the MDR1 P-glycoprotein. Hexakis(2- methoxyisobutyl isonitrile)technetium(I) (Tc-SESTAMIBI), a γ-emitting lipophilic cationic metallopharmaceutical, has recently been shown to be a P-glycoprotein transport substrate. Exploiting the negligible lipid membrane adsorption properties of this organometallic substrate, we studied the transport kinetics, pharmacology, drug binding, and modulation of P-glycoprotein in cell preparations derived from a variety of species and selection strategies, including SW-1573, V79, Alex, and CHO drug-sensitive cells and in IT A, LZ-8, and Alex/A.5 MDR cells. Rapid cell accumulation (t1/2 ≈ 6 min) of the agent to a steady state was observed which was inversely proportional to immunodetectable levels of P-glycoprotein. Many MDR cytotoxic agents inhibited P-glycoprotein-mediated Tc-SESTAMIBI efflux, thereby enhancing organometallic cation accumulation. Median effective concentrations (EC50; wM) were as follows: vinblastine, 13; daunomycin, 55; idarubicin, 65; actinomycin D, 235; colchicine, minimal inhibition; adriamycin, no effect. P-glycoprotein modulators generally demonstrated significantly greater potency (EC50; M): SDZ PSC 833, 0.08; cyclosporin A, 1.3; verapamil, 4.1; quinidine, 6.4; prazosin, >300. Modulator-induced enhancement up to 100-fold was observed with Hill coefficients %1, consistent with simple Michaelis-Menten kinetics. Vanadate was an efficacious transport inhibitor, while agents usually not included in the MDR phenotype were without effect. Scatchard analysis showed quinidine to be a noncompetitive inhibitor of P-glycoprotein-mediated Tc-SESTAMIBI transport, indicating allosteric effector sites on P-glycoprotein. The lipid bilayer adsorbing agents tetraphenyl borate and phloretin induced large increases in final Tc-SESTAMIBI accumulation, showing maximal accumulations 2-fold greater than classic MDR modulators and Hill coefficients » 2. In V79 and 77A cells, modulators of PKC activity altered Tc-SESTAMIBI accumulation, while there was no indication of modulation of P-glycoproteinmediated Tc-SESTAMIBI transport by hypotonic buffer, extracellular ATP, Cl-, or K+ (membrane potential). While recognized and avidly transported by the P-glycoprotein at buffer concentrations as low as 7 pM, Tc-SESTAMIBI at up to 100 uM only minimally modulated the cytotoxic action of colchicine, doxorubicin, or vinblastine in MDR cells. In conclusion, transport analysis with Tc-SESTAMIBI is a sensitive assay for detecting functional expression of low levels of P-glycoprotein and for the quantitative characterization of transporter modulation and regulation. The biochemical data favor a high Km, high capacity allosterically modulated translocation mechanism for P-glycoprotein-mediated transport of this organometallic cation. In addition, the known physicochemical properties of Tc-SESTAMIBI combined with effects of the membrane adsorbing agents indicate that lipid-protein interactions are critical for transport of this metallopharmaceutical and would suggest that this drug gains access to protein transport domains from the lipid phase with rapid time constants.

UR - http://www.scopus.com/inward/record.url?scp=0029112418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029112418&partnerID=8YFLogxK

U2 - 10.1021/bi00038a015

DO - 10.1021/bi00038a015

M3 - Article

C2 - 7547962

AN - SCOPUS:0029112418

VL - 34

SP - 12210

EP - 12220

JO - Biochemistry

JF - Biochemistry

SN - 0006-2960

IS - 38

ER -